20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Science Behind Enzalutamide: How It Fights Prostate Cancer

Understanding the scientific underpinnings of cancer therapies is crucial for appreciating their impact and potential. Enzalutamide, a pivotal drug in the treatment of prostate cancer, exemplifies targeted therapy at its best. Its effectiveness lies in its specific mechanism of action, directly confronting the hormonal drivers of the disease.

At its core, prostate cancer is often driven by androgens, hormones like testosterone that stimulate the growth of prostate cells. Enzalutamide functions as a potent androgen receptor (AR) antagonist. This means it binds to the AR, but instead of activating it to promote cell growth, it blocks the receptor. More profoundly, unlike earlier antiandrogens, Enzalutamide not only prevents AR translocation to the cell nucleus but also inhibits the binding of AR to DNA and coactivator proteins. This comprehensive blockade significantly curtails the signaling cascades that fuel prostate cancer progression.

The clinical implications of this precise mechanism are substantial. By inhibiting AR signaling, Enzalutamide has demonstrated efficacy in slowing tumor growth, reducing PSA levels, and most importantly, extending the survival of patients with advanced prostate cancer. Its role in treating metastatic castration-resistant prostate cancer (mCRPC) and other aggressive forms of the disease underscores its therapeutic value.

For those seeking to buy Enzalutamide, understanding its scientific basis reinforces its importance. The consistent supply of high-purity Enzalutamide is essential for pharmaceutical development and patient treatment. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to upholding the highest standards in the production of Enzalutamide, ensuring that researchers and manufacturers have access to a reliable source of this critical active pharmaceutical ingredient.

The ongoing research into Enzalutamide and its potential applications continues to expand our understanding of AR-driven cancers. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting this scientific endeavor by providing the essential building blocks for such life-saving medications, contributing to the advancement of cancer treatment strategies.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Navigating Prostate Cancer Treatment: Enzalutamide and Beyond

Next: Ensuring Access to Enzalutamide: Pricing, Support, and Availability

All Rights Reserved